Longevity – A Discussion From The Singapore Legal Perspective

I. Introduction

This article is the first in our multi-part series centring around the topic of longevity from the perspective of Singapore law.

As a preliminary framework, the longevity industry consists of several distinct but intersecting segments and domains, including the following:

1. geroscience;
2. biomedicine (i.e. personalised, preventive, and regenerative medicines);
3. progressive clinics and progressive wellness centres;
4. AgeTech; and
5. finance.

We believe that the relevance and significance of the longevity industry in Singapore cannot be overstated, and is underscored by several factors, of which the following are key:

1. Singapore's demographic is rapidly ageing, with Singaporeans living longer and healthier lives as Singapore has an efficient and widespread system of healthcare. As of 2021, Singaporean women can expect to live 85.9 years with 75.8 years in good health, while Singaporean men can expect to live 81.1 years with 72.6 years